Cargando…

Pattern of Radiotherapy Treatment in Low-Risk, Intermediate-Risk, and High-Risk Prostate Cancer Patients: Analysis of National Cancer Database

SIMPLE SUMMARY: Prostate cancer (PCa) is the most common cancer and the second leading cause of cancer-related mortality among males in the US. Definitive radiation therapy (RT) plays an important role in curative-intent treatment for localized PCa and can be delivered with several different techniq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agrawal, Rishabh, Dey, Asoke, Datta, Sujay, Nassar, Ana, Grubb, William, Traughber, Bryan, Biswas, Tithi, Ove, Roger, Podder, Tarun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688758/ https://www.ncbi.nlm.nih.gov/pubmed/36428595 http://dx.doi.org/10.3390/cancers14225503

Ejemplares similares

Dose uncertainty due to needle-tip localization error in prostate seed implantation
por: Xu, Zhengzheng, et al.
Publicado: (2022)

Effect of applicator removal from target volume for cervical cancer patients treated with Venezia high-dose-rate brachytherapy applicator
por: Xu, ZhengZheng, et al.
Publicado: (2022)

Primary squamous cell carcinoma of the prostate: a case report of a rare clinical entity
por: Biswas, Tithi, et al.
Publicado: (2015)

Race, insurance type, and stage of presentation among lung cancer patients
por: Efird, Jimmy T, et al.
Publicado: (2014)

Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
por: Amit, Uri, et al.
Publicado: (2019)

Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer
por: Kishan, Amar U., et al.
Publicado: (2019)

Advances in Radiotherapy for Prostate Cancer Treatment
por: Podder, Tarun, et al.
Publicado: (2016)

Cone beam computed tomography—the need for future guidance
por: Efird, Jimmy T., et al.
Publicado: (2022)

Reduction of seed motion using a bio‐absorbable polymer coating during permanent prostate brachytherapy using a mick applicator technique
por: Warrell, Gregory R., et al.
Publicado: (2018)

Hypofractionated Radiotherapy in Intermediate-Risk Prostate Cancer Patients: Long-Term Results
por: Valeriani, Maurizio, et al.
Publicado: (2022)

Grade and stage misclassification in intermediate unfavorable‐risk prostate cancer radiotherapy candidates
por: Sorce, Gabriele, et al.
Publicado: (2022)

A Pilot Study Examining the Prognostic Utility of Tumor Shrinkage on Cone-Beam Computed Tomography (CBCT) for Stage III Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Definitive Chemoradiation
por: Kang, Kylie H., et al.
Publicado: (2021)

Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer
por: Anwar, Mekhail, et al.
Publicado: (2016)

Hypofractionated Radiotherapy in Localized, Low–Intermediate-Risk Prostate Cancer: Current and Future Prospectives
por: Lo Greco, Maria Chiara, et al.
Publicado: (2023)

Comparative evaluation of hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate and high risk prostate cancer
por: Soni, Abhishek, et al.
Publicado: (2022)

Comparative analysis for renal stereotactic body radiotherapy using Cyberknife, VMAT and proton therapy based treatment planning
por: Baydoun, Atallah, et al.
Publicado: (2018)

Clinical outcomes of low-dose-rate brachytherapy based radiotherapy for intermediate risk prostate cancer
por: Okamoto, Keisei, et al.
Publicado: (2020)

Cost-effectiveness analysis of ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy for intermediate- to high-risk localized prostate cancer
por: He, Jiaoxue, et al.
Publicado: (2023)

Advancing Risk Assessment of Intermediate Risk Prostate Cancer Patients
por: Drachenberg, Darrel, et al.
Publicado: (2019)

The baseline recurrence risk of patients with intermediate-risk cervical cancer
por: Yoneoka, Yutaka, et al.
Publicado: (2021)

Comparison of multiparametric MRI‐based and transrectal ultrasound‐based preplans with intraoperative ultrasound‐based planning for low dose rate interstitial prostate seed implantation
por: Fredman, Elisha T., et al.
Publicado: (2019)

Synthetic CT Generation of the Pelvis in Patients With Cervical Cancer: A Single Input Approach Using Generative Adversarial Network
por: BAYDOUN, ATALLAH, et al.
Publicado: (2021)

Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
por: Kim, Hun Jung, et al.
Publicado: (2016)

Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial
por: Nicholls, Luke, et al.
Publicado: (2020)

Chemoradiotherapy is not superior to radiotherapy alone after radical surgery for cervical cancer patients with intermediate-risk factor
por: Kim, Hakyoung, et al.
Publicado: (2019)

The impacts of minimally invasive surgery on intermediate- or high-risk cervical cancer patients received adjuvant radiotherapy
por: Zhang, Qiying, et al.
Publicado: (2022)

Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A systematic review and meta-analysis
por: Chen, Jiuzhou, et al.
Publicado: (2023)

Active Surveillance for Intermediate Risk Prostate Cancer
por: Dall'Era, Marc A., et al.
Publicado: (2016)

Abdominopelvic MR to CT registration using a synthetic CT intermediate
por: Heo, Jin Uk, et al.
Publicado: (2022)

Intermediate risk of choledocholithiasis: are we on the right path?
por: Girón, Felipe, et al.
Publicado: (2023)

Comparative Effectiveness of Radiotherapy versus Focal Laser Ablation in Patients with Low and Intermediate Risk Localized Prostate Cancer
por: Zhou, Xianghong, et al.
Publicado: (2020)

The Association between Age, Comorbidities and Use of Radiotherapy in Women with Breast Cancer: Implications for Survival
por: Efird, Jimmy T., et al.
Publicado: (2018)

Cancer risk after radiotherapy for breast cancer
por: Levi, F, et al.
Publicado: (2006)

Hypofractionated radiotherapy versus conventional radiotherapy in patients with intermediate- to high-risk localized prostate cancer: a meta-analysis of randomized controlled trials
por: Guo, Wei, et al.
Publicado: (2019)

MRI for managing intermediate & low risk prostate cancer
por: Padhani, Anwar R
Publicado: (2014)

Active surveillance in intermediate risk prostate cancer: is it safe?
por: Henk, G. van der Poel, et al.
Publicado: (2016)

Active surveillance in intermediate risk prostate cancer: is it safe?
por: Krishnananthan, Nishanth, et al.
Publicado: (2016)

A Hidden Epidemic of “Intermediate Risk” Oropharynx Cancer
por: Sandulache, Vlad C., et al.
Publicado: (2019)

Complications from Stereotactic Body Radiotherapy for Lung Cancer
por: Kang, Kylie H., et al.
Publicado: (2015)

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression
por: Kil, Whoon Jong, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_omd6t9b08dms5b500d907l0612